Townsquare Capital LLC trimmed its position in Humana Inc. (NYSE:HUM - Free Report) by 84.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,194 shares of the insurance provider's stock after selling 11,647 shares during the period. Townsquare Capital LLC's holdings in Humana were worth $557,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of HUM. Vanguard Group Inc. grew its holdings in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the period. Norges Bank acquired a new stake in shares of Humana during the fourth quarter worth about $416,202,000. Pzena Investment Management LLC lifted its holdings in shares of Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares in the last quarter. Boston Partners grew its position in shares of Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after purchasing an additional 893,637 shares during the period. Finally, Invesco Ltd. increased its stake in Humana by 29.8% during the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after purchasing an additional 550,692 shares in the last quarter. Institutional investors own 92.38% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the stock. Barclays increased their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research report on Friday, April 11th. Truist Financial boosted their price target on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a report on Friday, April 11th. Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. StockNews.com upgraded Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $284.90.
View Our Latest Analysis on HUM
Humana Trading Up 1.8 %
Shares of HUM traded up $4.76 during trading hours on Wednesday, hitting $263.68. 1,092,427 shares of the stock were exchanged, compared to its average volume of 1,757,224. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business has a 50-day moving average of $265.74 and a 200-day moving average of $270.19. The firm has a market capitalization of $31.82 billion, a P/E ratio of 26.50, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.
Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts expect that Humana Inc. will post 16.47 EPS for the current year.
Humana Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.34%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 35.58%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.